Navigation Links
Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
Date:12/10/2009

NEW YORK, Dec. 10 /PRNewswire-FirstCall/ --

  • Company remains focused on speeding innovation to patients and delivering greater value to customers.
  • Five strategic business units prepared to maximize growth opportunities in multiple therapeutic areas and geographies.
  • Lilly advances ranking to ninth in worldwide pharmaceutical sales; fastest growing top 10 pharma company in the U.S., major Europe and globally.
  • R&D pipeline boasts more than 60 molecules in clinical development, including 25 in Phases II and III.
  • Company expects 10 Phase III molecules in 2011, plans to launch 2 new medicines per year beginning in 2013.
  • Continued strong cash flow expected to fund R&D investment and business development transactions, while at least maintaining the current dividend.
  • 2010 EPS guidance set at $4.65 to $4.85, excluding the potential impact of health care reform in the U.S.
  • Longer-term guidance reconfirmed at low double-digit compound annual EPS growth between 2007 and 2011

At its annual meeting today with the investment community, Eli Lilly and Company (NYSE: LLY) highlighted how its innovation-based strategy will enable it to better serve patients and compete effectively in a challenging health care environment. The company also detailed the progress being made in its labs and across its five new business units on an expanding pipeline of innovative molecules and marketed medicines, and provided investors with the company's financial guidance for 2010.

"In 2009, Lilly has once again exhibited strong performance in a tough environment, and we've continued with a series of actions aimed at speeding innovation to patients and delivering greater value to our customers," said John C. Lechle
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
(Date:5/23/2013)... ARBOR, Mich. , May 23, 2013  Every day, ... flow of air to his lungs. April and ... the dire predictions weren,t true. "Quite a few ... the hospital alive," says April Gionfriddo , ... were desperate. Anything that would work, we would take it ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... 2011  Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today ... edoxaban, a direct oral once-daily Factor Xa inhibitor, significantly ... total knee or hip arthroplasty, when compared to enoxaparin. ... composite of deep vein thrombosis (DVT) and pulmonary embolism ...
... SHANGHAI, Dec. 12, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: ... medical-device research and development outsourcing company with operations in ... of its fifth Life Science and Chemistry Awards, held ... Beijing. The theme of this year,s awards ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards 2WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards 3
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- Two out of ... people, a new study found. The study authors, ... stigma is a significant barrier to the treatment of ... this bias is necessary to improve care for the ... "Bias can affect clinical care and the doctor-patient relationship, ...
(Date:5/24/2013)... 23 May 2013, Paris, France: A new investigational device ... use with the Sapien XT Transcatheter Heart Valve was ... first-in-human feasibility study of its use in high-risk aortic ... system acts as an anchor to help stabilise the ... native leaflets in the heart are captured between the ...
(Date:5/24/2013)... Oregon Health & Science University highlights an ingenious method ... the highly evasive HIV virus that causes AIDS. The ... approach to develop its own HIV vaccine candidate, which ... This latest research finding will be published in the ... . , "A major challenge in developing an ...
(Date:5/24/2013)... Fit Yummy Mummy, a fitness program ... are trying to get rid of the belly fat ... for women who want to combine exercises with nutrition ... Stan Stevenson, prompting an investigative review. , “Holly's Rigsby's ... wide variety of motivational strategies, nutritional plans, proper diets, ...
(Date:5/24/2013)... Electric™ Energy Straws, an exciting new brand of on-the-go energy ... be the lead sponsor on Munoz’s Chevy #26 car at ... who is part of Andretti Autosports’ fantastic five racing team, ... to be named the 2013 Indy 500 Fastest Rookie Driver ... , While Munoz is grabbing headlines around the racing world ...
Breaking Medicine News(10 mins):Health News:Many Medical Students Have Anti-Fat Bias, Study Finds 2Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3
... returned to Iraq's holy city of Najaf on Friday after ... head of one of the most powerful parties in the ... included medical tests in the United States and treatment in ... and will be there for a long time, after he ...
... now breathe a sigh of relief for researchers at ... developed two robotic devices that mimic the human ankle, ... ,Dr. Hugh Herr, Assistant Professor and Director of the ... Discovery News as saying that these spring-enabled, motor-driven devices ...
... identified a tiny bit of genetic code, which helps the ... ,The genetic code is called miR-34a, a microRNA ... are likely to become malignant because of damaged genes in ... acid (RNA), which stick to messenger RNAs, and prevent proteins ...
... death campaigners on Friday expressed concerns that the number of ... in Australia. ,The number of children dying from ... to 87 in 2005, SIDS and Kids Western Australia spokeswoman ... safe sleeping practices for babies had reduced cot deaths from ...
... has issued a warning in all districts after reports from ... eradicated from the world 30 years ago, along the Bangladesh-Myanmar ... Sanchita Bakshi said border security agencies have been asked to ... the symptoms of the disease. ,Local reports said ...
... TV reality show highlighting the need for more organ donors, ... a swirl of controversy, a Dutch channel Friday was to ... her kidney. ,The controversy stirred by "The Big ... but public broadcaster BNN is determined to go ahead. ...
Cached Medicine News:Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2Health News:Genetic Code That Helps Kill Colon Cancer Cells Identified 2Health News:Small Pox Scare Put West Bengal on High Alert 2Health News:Shock TV Reality Organ Donor Show Goes on Air 2Health News:Shock TV Reality Organ Donor Show Goes on Air 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: